Saturday 17 October 2026
Export AVBP’s income statement to Excel — free account
ArriVent BioPharma, Inc.
AVBP Healthcare Biotechnology
In the quarter to June 2026, EPS fell 16.7% and free cash flow fell 51.5%, each against the same quarter a year earlier.
16.66
0.13
−0.77%
Follow AVBP
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|
Current Ratio |
23.63 | 21.84 | 13.76 | 13.14 | 12.83 |
Net Debt/EBITDA |
0.72 | 4.43 | 2.02 | 2.32 | 1.73 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.24 | 1.18 | 0.81 | 0.87 | 0.97 |
Capex/Depreciation |
— | — | — | — | 0.00 |
| 0.00% | 55.19% | 58.19% | (154.10%) | (58.88%) | |
| 0.00% | (32.68%) | (40.08%) | (36.75%) | (54.70%) | |
ROIC |
(818.42%) | (207.99%) | (5,134.22%) | (151.95%) | 0.00% |
Return on Tangible Assets |
(125.46%) | (21.18%) | (46.74%) | (38.38%) | (54.18%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(17.70) | (34.17) | (26.08) | (2.23) | (4.18) |
Cash per Share |
52.43 | 127.93 | 70.24 | 6.95 | 8.13 |
Shareholders Equity per Share |
57.98 | 136.62 | 70.67 | 8.19 | 7.99 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
57.98 | 136.62 | 70.67 | 8.19 | 7.99 |
Free Cash Flow |
(12.59) | (43.63) | (55.84) | (70.21) | (160.59) |
Working Capital |
41.13 | 174.26 | 148.34 | 209.71 | 306.95 |
Net Current Asset Value |
41.13 | 174.25 | 148.17 | 209.69 | 306.95 |
| Other line items | |||||
Quick Ratio |
20.51 | 19.54 | 12.94 | 12.67 | 12.06 |
Depreciation/Fixed assets |
— | — | — | — | 0.00 |
Cash ROIC |
(16.03%) | (12.91%) | (18.51%) | (14.73%) | (25.90%) |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(17.70) | (34.17) | (26.08) | (2.23) | (4.18) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
— | 1.69 | 3.81 | 4.16 | 4.86 |
Average Assets |
— | 112.94 | 172.97 | 219.02 | 304.06 |
Average Common Equity |
— | (66.88) | (119.15) | 52.23 | 282.44 |
Columns are period end dates